Safilo Group S.p.A.
Get $10 bonus on your first $100 deposit for SAFLF
Get $10 bonus on your first $100 deposit for SAFLF
Safilo Group S.p.A. (SAFLF) Stock Competitors & Peer Comparison
See (SAFLF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SAFLF | $2.31 | +3.12% | 906.6M | 16.50 | $0.14 | N/A |
| SRTOY | $20.20 | +1.48% | 192.6B | 61.86 | $0.32 | +0.22% |
| MECNY | $88.63 | +0.00% | 107.5B | N/A | N/A | N/A |
| ESLOY | $114.94 | -0.62% | 107.2B | 41.02 | $2.84 | +1.93% |
| ESLOF | $231.10 | +0.75% | 106.8B | 39.54 | $5.83 | +1.95% |
| SOAGY | $50.33 | +0.33% | 73.2B | 96.39 | $0.52 | +0.18% |
| HOCPY | $184.47 | +0.11% | 62.8B | 48.71 | $3.83 | +0.68% |
| HOCPF | $165.00 | +0.00% | 55.8B | 43.31 | $3.81 | +1.02% |
| RSMDF | $19.66 | +0.00% | 28.6B | 19.47 | $1.01 | +1.02% |
| TRUMY | $13.56 | -1.09% | 19.9B | 24.53 | $0.55 | +1.33% |
Stock Comparison
SAFLF vs SRTOY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SRTOY has a market cap of 192.6B. Regarding current trading prices, SAFLF is priced at $2.31, while SRTOY trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SRTOY's P/E ratio is 61.86. In terms of profitability, SAFLF's ROE is +0.12%, compared to SRTOY's ROE of +0.06%. Regarding short-term risk, SAFLF is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SRTOY's competition here
SAFLF vs MECNY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, MECNY has a market cap of 107.5B. Regarding current trading prices, SAFLF is priced at $2.31, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas MECNY's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, SAFLF and MECNY have similar daily volatility (0.00).Check MECNY's competition here
SAFLF vs ESLOY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ESLOY has a market cap of 107.2B. Regarding current trading prices, SAFLF is priced at $2.31, while ESLOY trades at $114.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ESLOY's P/E ratio is 41.02. In terms of profitability, SAFLF's ROE is +0.12%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, SAFLF is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check ESLOY's competition here
SAFLF vs ESLOF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ESLOF has a market cap of 106.8B. Regarding current trading prices, SAFLF is priced at $2.31, while ESLOF trades at $231.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ESLOF's P/E ratio is 39.54. In terms of profitability, SAFLF's ROE is +0.12%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, SAFLF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check ESLOF's competition here
SAFLF vs SOAGY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SOAGY has a market cap of 73.2B. Regarding current trading prices, SAFLF is priced at $2.31, while SOAGY trades at $50.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SOAGY's P/E ratio is 96.39. In terms of profitability, SAFLF's ROE is +0.12%, compared to SOAGY's ROE of +0.06%. Regarding short-term risk, SAFLF is less volatile compared to SOAGY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SOAGY's competition here
SAFLF vs HOCPY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, HOCPY has a market cap of 62.8B. Regarding current trading prices, SAFLF is priced at $2.31, while HOCPY trades at $184.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas HOCPY's P/E ratio is 48.71. In terms of profitability, SAFLF's ROE is +0.12%, compared to HOCPY's ROE of +0.25%. Regarding short-term risk, SAFLF is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check HOCPY's competition here
SAFLF vs HOCPF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, HOCPF has a market cap of 55.8B. Regarding current trading prices, SAFLF is priced at $2.31, while HOCPF trades at $165.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas HOCPF's P/E ratio is 43.31. In terms of profitability, SAFLF's ROE is +0.12%, compared to HOCPF's ROE of +0.25%. Regarding short-term risk, SAFLF is less volatile compared to HOCPF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check HOCPF's competition here
SAFLF vs RSMDF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, RSMDF has a market cap of 28.6B. Regarding current trading prices, SAFLF is priced at $2.31, while RSMDF trades at $19.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas RSMDF's P/E ratio is 19.47. In terms of profitability, SAFLF's ROE is +0.12%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, SAFLF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check RSMDF's competition here
SAFLF vs TRUMY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TRUMY has a market cap of 19.9B. Regarding current trading prices, SAFLF is priced at $2.31, while TRUMY trades at $13.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TRUMY's P/E ratio is 24.53. In terms of profitability, SAFLF's ROE is +0.12%, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, SAFLF is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check TRUMY's competition here
SAFLF vs SDMHF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SDMHF has a market cap of 19.5B. Regarding current trading prices, SAFLF is priced at $2.31, while SDMHF trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SDMHF's P/E ratio is 63.49. In terms of profitability, SAFLF's ROE is +0.12%, compared to SDMHF's ROE of +0.07%. Regarding short-term risk, SAFLF and SDMHF have similar daily volatility (0.00).Check SDMHF's competition here
SAFLF vs TRUMF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TRUMF has a market cap of 18.3B. Regarding current trading prices, SAFLF is priced at $2.31, while TRUMF trades at $12.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TRUMF's P/E ratio is 22.55. In terms of profitability, SAFLF's ROE is +0.12%, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, SAFLF and TRUMF have similar daily volatility (0.00).Check TRUMF's competition here
SAFLF vs SAUHF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SAUHF has a market cap of 17.8B. Regarding current trading prices, SAFLF is priced at $2.31, while SAUHF trades at $104.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SAUHF's P/E ratio is 39.95. In terms of profitability, SAFLF's ROE is +0.12%, compared to SAUHF's ROE of +0.17%. Regarding short-term risk, SAFLF is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SAUHF's competition here
SAFLF vs SAUHY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SAUHY has a market cap of 16.9B. Regarding current trading prices, SAFLF is priced at $2.31, while SAUHY trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SAUHY's P/E ratio is 37.96. In terms of profitability, SAFLF's ROE is +0.12%, compared to SAUHY's ROE of +0.17%. Regarding short-term risk, SAFLF is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SAUHY's competition here
SAFLF vs SUVPF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SUVPF has a market cap of 16.9B. Regarding current trading prices, SAFLF is priced at $2.31, while SUVPF trades at $244.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SUVPF's P/E ratio is 94.40. In terms of profitability, SAFLF's ROE is +0.12%, compared to SUVPF's ROE of +0.06%. Regarding short-term risk, SAFLF is less volatile compared to SUVPF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SUVPF's competition here
SAFLF vs SARTF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SARTF has a market cap of 15.6B. Regarding current trading prices, SAFLF is priced at $2.31, while SARTF trades at $226.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SARTF's P/E ratio is 87.72. In terms of profitability, SAFLF's ROE is +0.12%, compared to SARTF's ROE of +0.06%. Regarding short-term risk, SAFLF is less volatile compared to SARTF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SARTF's competition here
SAFLF vs CLPBY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CLPBY has a market cap of 15B. Regarding current trading prices, SAFLF is priced at $2.31, while CLPBY trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CLPBY's P/E ratio is 24.70. In terms of profitability, SAFLF's ROE is +0.12%, compared to CLPBY's ROE of +0.25%. Regarding short-term risk, SAFLF is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CLPBY's competition here
SAFLF vs SSSGY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SSSGY has a market cap of 13.6B. Regarding current trading prices, SAFLF is priced at $2.31, while SSSGY trades at $39.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SSSGY's P/E ratio is 75.87. In terms of profitability, SAFLF's ROE is +0.12%, compared to SSSGY's ROE of +0.06%. Regarding short-term risk, SAFLF and SSSGY have similar daily volatility (0.00).Check SSSGY's competition here
SAFLF vs CLPBF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CLPBF has a market cap of 13.5B. Regarding current trading prices, SAFLF is priced at $2.31, while CLPBF trades at $65.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CLPBF's P/E ratio is 23.92. In terms of profitability, SAFLF's ROE is +0.12%, compared to CLPBF's ROE of +0.25%. Regarding short-term risk, SAFLF is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CLPBF's competition here
SAFLF vs FSPKF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, FSPKF has a market cap of 13.5B. Regarding current trading prices, SAFLF is priced at $2.31, while FSPKF trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas FSPKF's P/E ratio is 52.32. In terms of profitability, SAFLF's ROE is +0.12%, compared to FSPKF's ROE of +0.30%. Regarding short-term risk, SAFLF and FSPKF have similar daily volatility (0.00).Check FSPKF's competition here
SAFLF vs OCPNF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, OCPNF has a market cap of 10.5B. Regarding current trading prices, SAFLF is priced at $2.31, while OCPNF trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas OCPNF's P/E ratio is 17.59. In terms of profitability, SAFLF's ROE is +0.12%, compared to OCPNF's ROE of +0.11%. Regarding short-term risk, SAFLF and OCPNF have similar daily volatility (0.00).Check OCPNF's competition here
SAFLF vs CNVVY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CNVVY has a market cap of 6.1B. Regarding current trading prices, SAFLF is priced at $2.31, while CNVVY trades at $12.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CNVVY's P/E ratio is 36.68. In terms of profitability, SAFLF's ROE is +0.12%, compared to CNVVY's ROE of +0.10%. Regarding short-term risk, SAFLF is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CNVVY's competition here
SAFLF vs CNVVF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CNVVF has a market cap of 5.7B. Regarding current trading prices, SAFLF is priced at $2.31, while CNVVF trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CNVVF's P/E ratio is 32.33. In terms of profitability, SAFLF's ROE is +0.12%, compared to CNVVF's ROE of +0.11%. Regarding short-term risk, SAFLF is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CNVVF's competition here
SAFLF vs SSMXY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SSMXY has a market cap of 5.4B. Regarding current trading prices, SAFLF is priced at $2.31, while SSMXY trades at $8.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SSMXY's P/E ratio is 18.49. In terms of profitability, SAFLF's ROE is +0.12%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, SAFLF is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SSMXY's competition here
SAFLF vs AHICF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, AHICF has a market cap of 5.4B. Regarding current trading prices, SAFLF is priced at $2.31, while AHICF trades at $20.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas AHICF's P/E ratio is 48.50. In terms of profitability, SAFLF's ROE is +0.12%, compared to AHICF's ROE of +0.12%. Regarding short-term risk, SAFLF is less volatile compared to AHICF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check AHICF's competition here
SAFLF vs SSMXF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SSMXF has a market cap of 5.3B. Regarding current trading prices, SAFLF is priced at $2.31, while SSMXF trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SSMXF's P/E ratio is 17.94. In terms of profitability, SAFLF's ROE is +0.12%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, SAFLF is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SSMXF's competition here
SAFLF vs ADDLF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, SAFLF is priced at $2.31, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, SAFLF's ROE is +0.12%, compared to ADDLF's ROE of +0.11%. Regarding short-term risk, SAFLF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check ADDLF's competition here
SAFLF vs YPHDF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, SAFLF is priced at $2.31, while YPHDF trades at $354.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas YPHDF's P/E ratio is 20.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to YPHDF's ROE of +0.27%. Regarding short-term risk, SAFLF is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check YPHDF's competition here
SAFLF vs FLMNF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, FLMNF has a market cap of 4.3B. Regarding current trading prices, SAFLF is priced at $2.31, while FLMNF trades at $50.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas FLMNF's P/E ratio is 20.30. In terms of profitability, SAFLF's ROE is +0.12%, compared to FLMNF's ROE of +0.20%. Regarding short-term risk, SAFLF is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check FLMNF's competition here
SAFLF vs FLMNY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, FLMNY has a market cap of 4.2B. Regarding current trading prices, SAFLF is priced at $2.31, while FLMNY trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas FLMNY's P/E ratio is 19.87. In terms of profitability, SAFLF's ROE is +0.12%, compared to FLMNY's ROE of +0.20%. Regarding short-term risk, SAFLF is less volatile compared to FLMNY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check FLMNY's competition here
SAFLF vs ANSLF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ANSLF has a market cap of 3.3B. Regarding current trading prices, SAFLF is priced at $2.31, while ANSLF trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ANSLF's P/E ratio is 32.49. In terms of profitability, SAFLF's ROE is +0.12%, compared to ANSLF's ROE of +0.07%. Regarding short-term risk, SAFLF and ANSLF have similar daily volatility (0.00).Check ANSLF's competition here
SAFLF vs ANSLY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, SAFLF is priced at $2.31, while ANSLY trades at $83.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ANSLY's P/E ratio is 22.45. In terms of profitability, SAFLF's ROE is +0.12%, compared to ANSLY's ROE of +0.07%. Regarding short-term risk, SAFLF is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check ANSLY's competition here
SAFLF vs CZMWF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CZMWF has a market cap of 2.7B. Regarding current trading prices, SAFLF is priced at $2.31, while CZMWF trades at $30.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CZMWF's P/E ratio is 16.60. In terms of profitability, SAFLF's ROE is +0.12%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, SAFLF is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CZMWF's competition here
SAFLF vs CZMWY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CZMWY has a market cap of 2.7B. Regarding current trading prices, SAFLF is priced at $2.31, while CZMWY trades at $30.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CZMWY's P/E ratio is 16.38. In terms of profitability, SAFLF's ROE is +0.12%, compared to CZMWY's ROE of +0.06%. Regarding short-term risk, SAFLF is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CZMWY's competition here
SAFLF vs SHWGY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SHWGY has a market cap of 2.5B. Regarding current trading prices, SAFLF is priced at $2.31, while SHWGY trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SHWGY's P/E ratio is 10.95. In terms of profitability, SAFLF's ROE is +0.12%, compared to SHWGY's ROE of +0.07%. Regarding short-term risk, SAFLF is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SHWGY's competition here
SAFLF vs EKTAY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, EKTAY has a market cap of 2.3B. Regarding current trading prices, SAFLF is priced at $2.31, while EKTAY trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas EKTAY's P/E ratio is -604.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to EKTAY's ROE of -0.00%. Regarding short-term risk, SAFLF and EKTAY have similar daily volatility (0.00).Check EKTAY's competition here
SAFLF vs TCGGY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, SAFLF is priced at $2.31, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TCGGY's P/E ratio is 27.27. In terms of profitability, SAFLF's ROE is +0.12%, compared to TCGGY's ROE of -0.09%. Regarding short-term risk, SAFLF is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check TCGGY's competition here
SAFLF vs EKTAF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, EKTAF has a market cap of 2.3B. Regarding current trading prices, SAFLF is priced at $2.31, while EKTAF trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas EKTAF's P/E ratio is -620.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to EKTAF's ROE of -0.00%. Regarding short-term risk, SAFLF and EKTAF have similar daily volatility (0.00).Check EKTAF's competition here
SAFLF vs SHWGF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SHWGF has a market cap of 2B. Regarding current trading prices, SAFLF is priced at $2.31, while SHWGF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SHWGF's P/E ratio is 9.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to SHWGF's ROE of +0.07%. Regarding short-term risk, SAFLF is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SHWGF's competition here
SAFLF vs TCHBF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TCHBF has a market cap of 2B. Regarding current trading prices, SAFLF is priced at $2.31, while TCHBF trades at $156.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TCHBF's P/E ratio is -14.26. In terms of profitability, SAFLF's ROE is +0.12%, compared to TCHBF's ROE of -0.09%. Regarding short-term risk, SAFLF and TCHBF have similar daily volatility (0.00).Check TCHBF's competition here
SAFLF vs BOEUF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, SAFLF is priced at $2.31, while BOEUF trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas BOEUF's P/E ratio is 108.52. In terms of profitability, SAFLF's ROE is +0.12%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, SAFLF is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check BOEUF's competition here
SAFLF vs NPRRF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, SAFLF is priced at $2.31, while NPRRF trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas NPRRF's P/E ratio is 26.92. In terms of profitability, SAFLF's ROE is +0.12%, compared to NPRRF's ROE of N/A. Regarding short-term risk, SAFLF is less volatile compared to NPRRF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check NPRRF's competition here
SAFLF vs TGLVY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TGLVY has a market cap of 1.6B. Regarding current trading prices, SAFLF is priced at $2.31, while TGLVY trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TGLVY's P/E ratio is 39.55. In terms of profitability, SAFLF's ROE is +0.12%, compared to TGLVY's ROE of +0.03%. Regarding short-term risk, SAFLF is less volatile compared to TGLVY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check TGLVY's competition here
SAFLF vs BITGF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, SAFLF is priced at $2.31, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas BITGF's P/E ratio is 45.50. In terms of profitability, SAFLF's ROE is +0.12%, compared to BITGF's ROE of +0.04%. Regarding short-term risk, SAFLF is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check BITGF's competition here
SAFLF vs SAFLY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SAFLY has a market cap of 1.2B. Regarding current trading prices, SAFLF is priced at $2.31, while SAFLY trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SAFLY's P/E ratio is 14.72. In terms of profitability, SAFLF's ROE is +0.12%, compared to SAFLY's ROE of +0.12%. Regarding short-term risk, SAFLF is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SAFLY's competition here
SAFLF vs PBHDF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, PBHDF has a market cap of 1.2B. Regarding current trading prices, SAFLF is priced at $2.31, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, SAFLF's ROE is +0.12%, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, SAFLF and PBHDF have similar daily volatility (0.00).Check PBHDF's competition here
SAFLF vs TDVXF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TDVXF has a market cap of 1B. Regarding current trading prices, SAFLF is priced at $2.31, while TDVXF trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TDVXF's P/E ratio is 61.25. In terms of profitability, SAFLF's ROE is +0.12%, compared to TDVXF's ROE of +0.32%. Regarding short-term risk, SAFLF is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check TDVXF's competition here
SAFLF vs NNCSF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, NNCSF has a market cap of 850.9M. Regarding current trading prices, SAFLF is priced at $2.31, while NNCSF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas NNCSF's P/E ratio is 56.10. In terms of profitability, SAFLF's ROE is +0.12%, compared to NNCSF's ROE of +0.10%. Regarding short-term risk, SAFLF and NNCSF have similar daily volatility (0.00).Check NNCSF's competition here
SAFLF vs KSRBF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, KSRBF has a market cap of 841.7M. Regarding current trading prices, SAFLF is priced at $2.31, while KSRBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas KSRBF's P/E ratio is 33.29. In terms of profitability, SAFLF's ROE is +0.12%, compared to KSRBF's ROE of +0.04%. Regarding short-term risk, SAFLF and KSRBF have similar daily volatility (0.00).Check KSRBF's competition here
SAFLF vs HGYMF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, HGYMF has a market cap of 754.4M. Regarding current trading prices, SAFLF is priced at $2.31, while HGYMF trades at $34.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas HGYMF's P/E ratio is 184.16. In terms of profitability, SAFLF's ROE is +0.12%, compared to HGYMF's ROE of +0.00%. Regarding short-term risk, SAFLF is less volatile compared to HGYMF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check HGYMF's competition here
SAFLF vs GRRMF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, GRRMF has a market cap of 713.3M. Regarding current trading prices, SAFLF is priced at $2.31, while GRRMF trades at $20.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas GRRMF's P/E ratio is 26.47. In terms of profitability, SAFLF's ROE is +0.12%, compared to GRRMF's ROE of +0.02%. Regarding short-term risk, SAFLF is less volatile compared to GRRMF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check GRRMF's competition here
SAFLF vs JNDOF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, SAFLF is priced at $2.31, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, SAFLF's ROE is +0.12%, compared to JNDOF's ROE of +0.29%. Regarding short-term risk, SAFLF and JNDOF have similar daily volatility (0.00).Check JNDOF's competition here
SAFLF vs SPMXF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, SAFLF is priced at $2.31, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to SPMXF's ROE of -0.07%. Regarding short-term risk, SAFLF is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check SPMXF's competition here
SAFLF vs CLHLF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, SAFLF is priced at $2.31, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, SAFLF's ROE is +0.12%, compared to CLHLF's ROE of +0.16%. Regarding short-term risk, SAFLF and CLHLF have similar daily volatility (0.00).Check CLHLF's competition here
SAFLF vs GUERF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, SAFLF is priced at $2.31, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas GUERF's P/E ratio is 8.19. In terms of profitability, SAFLF's ROE is +0.12%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, SAFLF and GUERF have similar daily volatility (0.00).Check GUERF's competition here
SAFLF vs OPSSF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, SAFLF is priced at $2.31, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, SAFLF's ROE is +0.12%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, SAFLF is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check OPSSF's competition here
SAFLF vs TSNLF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TSNLF has a market cap of 239.7M. Regarding current trading prices, SAFLF is priced at $2.31, while TSNLF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TSNLF's P/E ratio is 23.81. In terms of profitability, SAFLF's ROE is +0.12%, compared to TSNLF's ROE of +0.24%. Regarding short-term risk, SAFLF is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check TSNLF's competition here
SAFLF vs EEOIF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, SAFLF is priced at $2.31, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, SAFLF's ROE is +0.12%, compared to EEOIF's ROE of N/A. Regarding short-term risk, SAFLF and EEOIF have similar daily volatility (0.00).Check EEOIF's competition here
SAFLF vs OTCFF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, OTCFF has a market cap of 16.8M. Regarding current trading prices, SAFLF is priced at $2.31, while OTCFF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas OTCFF's P/E ratio is -10.50. In terms of profitability, SAFLF's ROE is +0.12%, compared to OTCFF's ROE of +1.24%. Regarding short-term risk, SAFLF and OTCFF have similar daily volatility (0.00).Check OTCFF's competition here
SAFLF vs UEEC Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, UEEC has a market cap of 12.2M. Regarding current trading prices, SAFLF is priced at $2.31, while UEEC trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas UEEC's P/E ratio is -2.36. In terms of profitability, SAFLF's ROE is +0.12%, compared to UEEC's ROE of +1.00%. Regarding short-term risk, SAFLF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check UEEC's competition here
SAFLF vs BLMHF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, SAFLF is priced at $2.31, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, SAFLF's ROE is +0.12%, compared to BLMHF's ROE of N/A. Regarding short-term risk, SAFLF and BLMHF have similar daily volatility (0.00).Check BLMHF's competition here
SAFLF vs PXMVF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, SAFLF is priced at $2.31, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, SAFLF's ROE is +0.12%, compared to PXMVF's ROE of -6.46%. Regarding short-term risk, SAFLF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check PXMVF's competition here
SAFLF vs CBSC Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CBSC has a market cap of 4.5M. Regarding current trading prices, SAFLF is priced at $2.31, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CBSC's P/E ratio is -4.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to CBSC's ROE of +0.93%. Regarding short-term risk, SAFLF is less volatile compared to CBSC. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CBSC's competition here
SAFLF vs MCDA Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, SAFLF is priced at $2.31, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas MCDA's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to MCDA's ROE of N/A. Regarding short-term risk, SAFLF and MCDA have similar daily volatility (0.00).Check MCDA's competition here
SAFLF vs GVDI Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, GVDI has a market cap of 4.2M. Regarding current trading prices, SAFLF is priced at $2.31, while GVDI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas GVDI's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, SAFLF and GVDI have similar daily volatility (0.00).Check GVDI's competition here
SAFLF vs RSCF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, RSCF has a market cap of 3.8M. Regarding current trading prices, SAFLF is priced at $2.31, while RSCF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas RSCF's P/E ratio is -4.42. In terms of profitability, SAFLF's ROE is +0.12%, compared to RSCF's ROE of +0.10%. Regarding short-term risk, SAFLF and RSCF have similar daily volatility (0.00).Check RSCF's competition here
SAFLF vs NSTGQ Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, SAFLF is priced at $2.31, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, SAFLF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check NSTGQ's competition here
SAFLF vs TUTH Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TUTH has a market cap of 2.4M. Regarding current trading prices, SAFLF is priced at $2.31, while TUTH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TUTH's P/E ratio is -0.95. In terms of profitability, SAFLF's ROE is +0.12%, compared to TUTH's ROE of +0.27%. Regarding short-term risk, SAFLF is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check TUTH's competition here
SAFLF vs ECIA Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ECIA has a market cap of 1.4M. Regarding current trading prices, SAFLF is priced at $2.31, while ECIA trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ECIA's P/E ratio is -3.67. In terms of profitability, SAFLF's ROE is +0.12%, compared to ECIA's ROE of -0.22%. Regarding short-term risk, SAFLF is less volatile compared to ECIA. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check ECIA's competition here
SAFLF vs YBGJ Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, YBGJ has a market cap of 1.1M. Regarding current trading prices, SAFLF is priced at $2.31, while YBGJ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas YBGJ's P/E ratio is -0.95. In terms of profitability, SAFLF's ROE is +0.12%, compared to YBGJ's ROE of +0.38%. Regarding short-term risk, SAFLF and YBGJ have similar daily volatility (0.00).Check YBGJ's competition here
SAFLF vs OJSY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, SAFLF is priced at $2.31, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas OJSY's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to OJSY's ROE of N/A. Regarding short-term risk, SAFLF and OJSY have similar daily volatility (0.00).Check OJSY's competition here
SAFLF vs PDMI Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, SAFLF is priced at $2.31, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas PDMI's P/E ratio is -0.01. In terms of profitability, SAFLF's ROE is +0.12%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, SAFLF and PDMI have similar daily volatility (0.00).Check PDMI's competition here
SAFLF vs WHSI Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, SAFLF is priced at $2.31, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas WHSI's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, SAFLF and WHSI have similar daily volatility (0.00).Check WHSI's competition here
SAFLF vs BLFE Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, SAFLF is priced at $2.31, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas BLFE's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to BLFE's ROE of +3.67%. Regarding short-term risk, SAFLF and BLFE have similar daily volatility (0.00).Check BLFE's competition here
SAFLF vs QTXB Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, SAFLF is priced at $2.31, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas QTXB's P/E ratio is -0.05. In terms of profitability, SAFLF's ROE is +0.12%, compared to QTXB's ROE of +0.19%. Regarding short-term risk, SAFLF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check QTXB's competition here
SAFLF vs IMTH Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, IMTH has a market cap of 89.8K. Regarding current trading prices, SAFLF is priced at $2.31, while IMTH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas IMTH's P/E ratio is -0.03. In terms of profitability, SAFLF's ROE is +0.12%, compared to IMTH's ROE of -0.60%. Regarding short-term risk, SAFLF is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check IMTH's competition here
SAFLF vs LANZ Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, LANZ has a market cap of 74.5K. Regarding current trading prices, SAFLF is priced at $2.31, while LANZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas LANZ's P/E ratio is 2.70. In terms of profitability, SAFLF's ROE is +0.12%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, SAFLF is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check LANZ's competition here
SAFLF vs CEOS Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, CEOS has a market cap of 68.9K. Regarding current trading prices, SAFLF is priced at $2.31, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas CEOS's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to CEOS's ROE of +0.40%. Regarding short-term risk, SAFLF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check CEOS's competition here
SAFLF vs GMVDF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, SAFLF is priced at $2.31, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas GMVDF's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, SAFLF and GMVDF have similar daily volatility (0.00).Check GMVDF's competition here
SAFLF vs REMI Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, REMI has a market cap of 14K. Regarding current trading prices, SAFLF is priced at $2.31, while REMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas REMI's P/E ratio is -0.07. In terms of profitability, SAFLF's ROE is +0.12%, compared to REMI's ROE of -0.11%. Regarding short-term risk, SAFLF is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check REMI's competition here
SAFLF vs SDCCQ Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SDCCQ has a market cap of 13.4K. Regarding current trading prices, SAFLF is priced at $2.31, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, SAFLF and SDCCQ have similar daily volatility (0.00).Check SDCCQ's competition here
SAFLF vs MDIT Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, MDIT has a market cap of 8.7K. Regarding current trading prices, SAFLF is priced at $2.31, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas MDIT's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, SAFLF and MDIT have similar daily volatility (0.00).Check MDIT's competition here
SAFLF vs ASFX Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ASFX has a market cap of 7K. Regarding current trading prices, SAFLF is priced at $2.31, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ASFX's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, SAFLF is less volatile compared to ASFX. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check ASFX's competition here
SAFLF vs DGEN Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, SAFLF is priced at $2.31, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas DGEN's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, SAFLF and DGEN have similar daily volatility (0.00).Check DGEN's competition here
SAFLF vs SVSO Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, SAFLF is priced at $2.31, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SVSO's P/E ratio is -0.01. In terms of profitability, SAFLF's ROE is +0.12%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, SAFLF and SVSO have similar daily volatility (0.00).Check SVSO's competition here
SAFLF vs LFPI Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, LFPI has a market cap of 2.1K. Regarding current trading prices, SAFLF is priced at $2.31, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas LFPI's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, SAFLF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check LFPI's competition here
SAFLF vs INND Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, INND has a market cap of 1.5K. Regarding current trading prices, SAFLF is priced at $2.31, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas INND's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to INND's ROE of +0.09%. Regarding short-term risk, SAFLF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check INND's competition here
SAFLF vs SEYE Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, SAFLF is priced at $2.31, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SEYE's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to SEYE's ROE of N/A. Regarding short-term risk, SAFLF and SEYE have similar daily volatility (0.00).Check SEYE's competition here
SAFLF vs BGMD Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, SAFLF is priced at $2.31, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas BGMD's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to BGMD's ROE of +7.47%. Regarding short-term risk, SAFLF and BGMD have similar daily volatility (0.00).Check BGMD's competition here
SAFLF vs ADLI Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, SAFLF is priced at $2.31, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas ADLI's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, SAFLF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check ADLI's competition here
SAFLF vs VSMD Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, VSMD has a market cap of 802. Regarding current trading prices, SAFLF is priced at $2.31, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas VSMD's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, SAFLF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check VSMD's competition here
SAFLF vs TEVNF Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, TEVNF has a market cap of 744. Regarding current trading prices, SAFLF is priced at $2.31, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas TEVNF's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, SAFLF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for SAFLF.Check TEVNF's competition here
SAFLF vs HRAL Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, HRAL has a market cap of 347. Regarding current trading prices, SAFLF is priced at $2.31, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas HRAL's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to HRAL's ROE of +0.21%. Regarding short-term risk, SAFLF and HRAL have similar daily volatility (0.00).Check HRAL's competition here
SAFLF vs MICRD Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, MICRD has a market cap of 317. Regarding current trading prices, SAFLF is priced at $2.31, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas MICRD's P/E ratio is -0.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, SAFLF and MICRD have similar daily volatility (0.00).Check MICRD's competition here
SAFLF vs RGBOQ Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, SAFLF is priced at $2.31, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, SAFLF and RGBOQ have similar daily volatility (0.00).Check RGBOQ's competition here
SAFLF vs SECI Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, SECI has a market cap of 31. Regarding current trading prices, SAFLF is priced at $2.31, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas SECI's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to SECI's ROE of -0.00%. Regarding short-term risk, SAFLF and SECI have similar daily volatility (0.00).Check SECI's competition here
SAFLF vs VTEQ Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, SAFLF is priced at $2.31, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, SAFLF's ROE is +0.12%, compared to VTEQ's ROE of N/A. Regarding short-term risk, SAFLF and VTEQ have similar daily volatility (0.00).Check VTEQ's competition here
SAFLF vs MEDVD Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, MEDVD has a market cap of 0. Regarding current trading prices, SAFLF is priced at $2.31, while MEDVD trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas MEDVD's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to MEDVD's ROE of N/A. Regarding short-term risk, SAFLF and MEDVD have similar daily volatility (0.00).Check MEDVD's competition here
SAFLF vs OCPNY Comparison April 2026
SAFLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SAFLF stands at 906.6M. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, SAFLF is priced at $2.31, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SAFLF currently has a P/E ratio of 16.50, whereas OCPNY's P/E ratio is N/A. In terms of profitability, SAFLF's ROE is +0.12%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, SAFLF and OCPNY have similar daily volatility (0.00).Check OCPNY's competition here